KOR

e-Article

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up.
Document Type
journal article
Source
Journal of Clinical Oncology; 5/1/2021, Vol. 39 Issue 13, p1448-1457, 10p
Subject
Language
ISSN
0732183X